Polylactide microspheres for the modified release of corticosteroids

Area of Science:

• Materials Science
• Pharmaceutical Sciences
• Drug Delivery

Background:

• Steroidal drugs like prednisolone 21-acetate are crucial in treating various inflammatory and autoimmune conditions.
• Effective drug delivery systems are needed to control the release and improve the therapeutic efficacy of prednisolone 21-acetate.
• Biodegradable polymers, such as polylactide (PDLLA), offer potential for creating sustained-release drug formulations.

Purpose of the Study:

• To incorporate prednisolone 21-acetate into polylactide (PDLLA) microspheres.
• To characterize the physical and chemical properties of the resulting microspheres.
• To evaluate the in vitro drug release profile of prednisolone 21-acetate from the PDLLA microspheres.

Main Methods:

• Prednisolone 21-acetate was encapsulated into polylactide (PDLLA) microspheres using a single emulsion/solvent evaporation technique.
• Microsphere characterization included analysis of morphology (e.g., using scanning electron microscopy).
• Particle size distribution, drug content, production yield, and in vitro drug release kinetics were determined.

Main Results:

• The single emulsion/evaporation method successfully produced polylactide (PDLLA) microspheres containing prednisolone 21-acetate.
• Characterization data provided insights into the microspheres' morphology, particle size, and drug loading efficiency.
• In vitro release studies demonstrated the drug release behavior over time from the polymeric matrix.

Conclusions:

• Polylactide (PDLLA) microspheres are a viable system for the formulation of prednisolone 21-acetate.
• The developed microspheres exhibit characteristics suitable for controlled drug delivery applications.
• Further studies are warranted to explore the in vivo performance and therapeutic potential of these prednisolone 21-acetate loaded microspheres.